{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:31:05Z","timestamp":1772173865255,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.02.054","type":"journal-article","created":{"date-parts":[[2004,11,5]],"date-time":"2004-11-05T18:00:12Z","timestamp":1099677612000},"page":"1746-1751","source":"Crossref","is-referenced-by-count":49,"title":["Childhood mortality after oral polio immunisation campaign in Guinea-Bissau"],"prefix":"10.1016","volume":"23","author":[{"given":"Peter","family":"Aaby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Hedegaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Sodemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Nhante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Erik","family":"Veirum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Lisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.02.054_bib1","first-page":"123","article-title":"Sabin's vaccine used for nonspecific prevention of infant diarrhea of viral etiology","volume":"8","author":"Contreras","year":"1974","journal-title":"PAHO Bull"},{"key":"10.1016\/j.vaccine.2004.02.054_bib2","first-page":"191","article-title":"Potential use of non-pathogenic enterovimses for control of human disease","volume":"36","author":"Voroshilova","year":"1987","journal-title":"Prog Med Virol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/aje\/153.3.215","article-title":"Invited commentary: stopping polio immunization","volume":"153","author":"Hull","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries","volume":"311","author":"Aaby","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2004.02.054_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.321.7274.1435","article-title":"Routine vaccinations and child survival: follow-up study in Guinea-Bissau","volume":"321","author":"Kristensen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2004.02.054_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ije\/25.3.665","article-title":"Child mortality following standard, medium and high titre measles vaccination in West Africa","volume":"25","author":"Knudsen","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0264-410X(02)00441-3","article-title":"Routine vaccinations and child survival in war situation with high mortality: effect of gender","volume":"21","author":"Aaby","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.054_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/ije\/20.2.474","article-title":"Childhood mortality among users and non-users of primary health care in a rural West African community","volume":"20","author":"Velema","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/bmj.319.7214.878","article-title":"Nutritional status and mortality of refugees and residents in a non-camp setting during conflict: follow up study","volume":"319","author":"Aaby","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2004.02.054_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ije\/28.2.347","article-title":"Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy","volume":"28","author":"Garly","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib11","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0264-410X(00)00431-X","article-title":"Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine","volume":"19","author":"Garly","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.02.054_bib12","doi-asserted-by":"crossref","unstructured":"Veirum JE, Sodemann M, Biai S, Jakobsen M, Hedegaard K, Jensen H, et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine, in press. doi: 10.1016\/j.vaccine.2004.02.053.","DOI":"10.1016\/j.vaccine.2004.02.053"},{"key":"10.1016\/j.vaccine.2004.02.054_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/IAI.65.2.623-629.1997","article-title":"Adjuvant modulation of immune responses to tuberculosis subunit vaccines","volume":"65","author":"Lindblad","year":"1997","journal-title":"Infect Immunol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib14","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/315806","article-title":"Pertussis toxin sensitization alters the pathogenesis of subsequent respiratory syncytial virus infection","volume":"182","author":"Fischer","year":"2000","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2004.02.054_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/314952","article-title":"Th2 responses to inactivated Influenza virus can be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection","volume":"180","author":"Moran","year":"1999","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2004.02.054_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/259309a0","article-title":"Protection of mice against Babesia and Plasmodium with BCG","volume":"259","author":"Clark","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2004.02.054_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2249.1999.00954.x","article-title":"Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated and live polio vaccines","volume":"117","author":"Juhela","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2004.02.054_bib19","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJMra011223","article-title":"Vaccines and vaccination","volume":"345","author":"Ada","year":"2001","journal-title":"NEJM"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T23:22:50Z","timestamp":1682810570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":19,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007479"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}